Differential impacts of mineralocorticoid receptor antagonist potassium canrenoate on liver and renal changes in high fat diet-mediated early hepatocarcinogenesis model rats
Authors:
Open Access
- 1 January 2018
- journal article
- research article
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 43 (10) , 611-621
Abstract
Mineralocorticoid receptor (MR)/NADPH oxidase (NOX) signaling is involved in the development of obesity, insulin resistance, and renal diseases; however, the role of this signaling on steatotic preneoplastic liver lesions is not fully elucidated. We determined the effects of the MR antagonist potassium canrenoate (PC) on MR/NOX signaling in hepatic steatosis and preneoplastic glutathione S-transferase placental form (GST-P)-positive liver foci. Rats were subjected to a two-stage hepatocarcinogenesis model and fed with basal diet or high fat diet (HFD) that was co-administered with PC alone or in combination with the antioxidant alpha-glycosyl isoquercitrin (AGIQ). PC reduced obesity and renal changes (basophilic tubules that expressed MR and p22phox) but did not affect blood glucose tolerance and non-alcoholic fatty liver disease activity score (NAS) in HFD-fed rats. However, the drug increased the area of GST-P-positive liver foci that expressed MR and p22phox as well as increased expression of NOX genes (p22phox, Poldip2, and NOX4). PC in combination with AGIQ had the potential of inhibiting the effects of PC on the area of GST-P-positive liver foci and the effects were associated with increasing expression of an anti-oxidative enzyme (Catalase). The results suggested that MR/NOX signaling might be involved in development of preneoplastic liver foci and renal basophilic changes in HFD-fed rats; however, the impacts of PC were different in each organ.Keywords
This publication has 35 references indexed in Scilit:
- In vivo hepatic oxidative stress because of carbon tetrachloride toxicity: protection by melatonin and pinolineJournal of Pineal Research, 2010
- Aldosterone: Role in the Cardiometabolic Syndrome and Resistant HypertensionProgress in Cardiovascular Diseases, 2010
- Renal injury in the extremely obese patients with normal renal functionKidney International, 2008
- Renal sodium retention in cirrhotic rats depends on glucocorticoid-mediated activation of mineralocorticoid receptor due to decreased renal 11β-HSD-2 activityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Effect of Potassium Canrenoate, an Anti-aldosterone Agent, on Incidence of Ascites and Variceal Progression in CirrhosisClinical Gastroenterology and Hepatology, 2006
- Mutually dependent localization of megalin and Dab2 in the renal proximal tubuleAmerican Journal of Physiology-Renal Physiology, 2005
- Potassium Canrenoate, an Aldosterone Receptor Antagonist, Reduces Isoprenaline-Induced Cardiac Fibrosis in the RatThe Journal of Pharmacology and Experimental Therapeutics, 2004
- A medium‐term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicalsCancer Science, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Unique Renal Tubule Changes Induced in Rats and Mice by the Peroxisome Proliferators 2,4-Dichlorophenoxyacetic Acid (2,4-D) and WY-14643Toxicologic Pathology, 2001